Novo Nordisk’s Wegovy and copyright, both of those powered by semaglutide, have revolutionized obesity treatment as a result of unparalleled weight loss final results.California biotech behemoth Amgen ditched designs for an experimental weight loss pill in May but continues to be hoping for any slice of the marketplace with MariTide, a monthly in